Pantxika Bellecave

Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference #

Pantxika Bellecave, Jérôme Gouttenoire, M. Gajer et al. · Hepatology · 2009 · 152 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis

Tom Loosli, Stefanie Hossmann, Suzanne M Ingle et al. · The Lancet HIV · 2023 · 128 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +16

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Alessandro Cozzi‐Lepri, Marc Noguera-Julián, Francesca Di Giallonardo et al. · Journal of Antimicrobial Chemotherapy · 2014 · 126 citations · Full text

Life Sciences, Infectious Diseases, Hiv Control +16

Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system†

Pantxika Bellecave, Magdalena Filipowicz Sinnreich, Olivier Donzé et al. · Hepatology · 2009 · 118 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Prevalence and Evolution of Low Frequency HIV Drug Resistance Mutations Detected by Ultra Deep Sequencing in Patients Experiencing First Line Antiretroviral Therapy Failure

Marie-Anne Vandenhende, Pantxika Bellecave, Patrícia Recordon-Pinson et al. · PLoS ONE · 2014 · 51 citations · Full text

Life Sciences, Pharmacology, Molecular Virology +16